Larvol Delta - RealWorld-Effectiveness-of-Risankizumab-in-Patients-With-Psoriatic-Arthritis-6Month-Interim-Results-From-the-Observational-PErsistence-With-RISankizumab-PERIS-Study

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3568351

Carlo Selmi, MD; PhD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next